News

FILTER BY:
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Mizuho Americas joins forces with all women-led venture capital fund BBG VenturesMizuho Americas joins forces with all women-led venture capital fund BBG Ventures
Press Release

Mizuho Americas joins forces with all women-led venture capital fund BBG Ventures

May 31, 2023
SoFi positioned to profit from student loan refinancing, says Mizuho’s Dan DolevSoFi positioned to profit from student loan refinancing, says Mizuho’s Dan Dolev
News

SoFi positioned to profit from student loan refinancing, says Mizuho’s Dan Dolev

May 31, 2023
Investors are buying China tech stocks ‘very cautiously,’ says Mizuho AmericasInvestors are buying China tech stocks ‘very cautiously,’ says Mizuho Americas
News

Investors are buying China tech stocks ‘very cautiously,’ says Mizuho Americas

May 30, 2023
Medical technology is a good space for cover in recession times, says Mizuho’s Anthony PetroneMedical technology is a good space for cover in recession times, says Mizuho’s Anthony Petrone
News

Medical technology is a good space for cover in recession times, says Mizuho’s Anthony Petrone

May 25, 2023
The inaugural Mizuho Neuroscience Summit explored promising investment trends and the companies driving themThe inaugural Mizuho Neuroscience Summit explored promising investment trends and the companies driving them
Press Release

The inaugural Mizuho Neuroscience Summit explored promising investment trends and the companies driving them

May 24, 2023
Mizuho buys Greenhill to boost its US M&A presenceMizuho buys Greenhill to boost its US M&A presence
News

Mizuho buys Greenhill to boost its US M&A presence

May 23, 2023
Mizuho to acquire premier M&A advisory firm GreenhillMizuho to acquire premier M&A advisory firm Greenhill
Press Release

Mizuho to acquire premier M&A advisory firm Greenhill

May 22, 2023
Blocking the Horizon-Amgen deal will be worse for pharma than for biotech, says Mizuho’s Jared HolzBlocking the Horizon-Amgen deal will be worse for pharma than for biotech, says Mizuho’s Jared Holz
News

Blocking the Horizon-Amgen deal will be worse for pharma than for biotech, says Mizuho’s Jared Holz

May 18, 2023
Top Calls: Mizuho's Pushback on Wedbush's Sofi DowngradeTop Calls: Mizuho's Pushback on Wedbush's Sofi Downgrade
News

Top Calls: Mizuho's Pushback on Wedbush's Sofi Downgrade

May 18, 2023
back-to-top-blue